FDA Grants Abbreviated Approval for Metformin Hydrochloride by Amneal Pharmaceuticals
The FDA has granted abbreviated approval for Metformin Hydrochloride under application ANDA078596 submitted by Amneal Pharmaceuticals.
Therapeutic Area
Therapeutic area intelligence for Diabetes with 90 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.